Skip to main content
Smart Investors Daily
SE

NASDAQ · SEER

Seer, Inc.

Healthcare · Biotechnology

$1.94

Down-$0.02 (-1.02%)

Updated Sep 2, 2026, 5:36 AM

SID Score

4.6/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
101.26M
P/E ratio
-1.29
Dividend yield
0.00%
52-week range
$1.55 – $2.41
Volume
411.46K
Avg. volume
127.71K

Price performance

SEER price history

1M range · 21 trading sessions · Daily adjusted prices

SEER closed at $1.94 after 21 trading sessions, down 12.22% for the selected period.

Last close
$1.94
Period change
-12.22%
Period low
$1.94
Period high
$2.21
Daily close
View OHLC price history
SEER OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 1, 2026$1.96$1.98$1.93$1.94411.46K
Aug 31, 2026$1.98$1.999$1.95$1.96145.12K
Aug 28, 2026$2.01$2.0185$1.98$1.98156.09K
Aug 27, 2026$2.00$2.04$2.00$2.01102.78K
Aug 26, 2026$2.03$2.04$2.005$2.02124.5K
Aug 25, 2026$2.05$2.0811$2.03$2.04100.64K
Aug 24, 2026$2.05$2.065$2.02$2.04207.12K
Aug 21, 2026$2.01$2.05$2.01$2.03117.1K
Aug 20, 2026$2.04$2.07$2.01$2.02176.52K
Aug 19, 2026$2.00$2.08$2.00$2.05182.54K
Aug 18, 2026$2.02$2.035$2.01$2.02258.29K
Aug 17, 2026$2.06$2.06$2.015$2.03308.06K
Aug 14, 2026$2.10$2.13$2.08$2.08126.39K
Aug 13, 2026$2.14$2.22$2.07$2.10529.71K
Aug 12, 2026$2.02$2.16$2.02$2.14515.09K
Aug 11, 2026$2.15$2.19$2.15$2.16203.14K
Aug 10, 2026$2.16$2.19$2.145$2.16150.88K
Aug 7, 2026$2.19$2.21$2.15$2.17268.26K
Aug 6, 2026$2.18$2.21$2.16$2.19381.38K
Aug 5, 2026$2.21$2.22$2.18$2.19155.61K
Aug 4, 2026$2.20$2.23$2.20$2.21288.23K

Latest SEER news

The latest Smart Investors Daily articles mentioning SEER.

SEER research

Overview

Company profile and research snapshot.

Company profile

Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$3.06
Implied upside
Analysts
7
SEER recent ratings
DateFirmRatingTarget
May 4, 2026Canaccord GenuityBuy
Aug 13, 2024Morgan StanleyEqual-Weight
Mar 5, 2024Morgan StanleyEqual-Weight
Feb 21, 2023Morgan StanleyEqual-Weight
Jan 4, 2023B of A SecuritiesUnderperform
Open full forecast

News briefing

No generated briefing is available yet.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.